Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 133 Records) |
| Query Trace: Neoplasms and FGFR1[original query] |
|---|
| Frequency of actionable molecular drivers in lung cancer patients with precocious brain metastases. Clinical neurology and neurosurgery 2021 Jul 208 106841. Hanke Benjamin, Jünger Stephanie T, Kirches Elmar, Waldt Natalie, Schreiber Jens, Lücke Eva, Franke Sabine, Sandalcioglu I Erol, Warnke Jan-Peter, Meisel Hans-Jörg, Prell Julian, Scheller Christian, Braunsdorf Werner E K, Preusser Matthias, Schildhaus Hans-Ulrich, Mawrin Christi |
| Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor Therapy. Urology 2021 6 157 93-101. Tully Karl H, Jütte Hendrik, Wirtz Ralph M, Jarczyk Jonas, Santiago-Walker Ademi, Zengerling Friedemann, Breyer Johannes, Sikic Danijel, Kriegmair Maximilian C, von Hardenberg Jost, Wullich Bernd, Taubert Helge, Weyerer Veronika, Stoehr Robert, Bolenz Christian, Burger Maximilian, Porubsky Stefan, Hartmann Arndt, Roghmann Florian, Erben Philipp, Eckstein Mark |
| Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations. Oncotarget 2021 4 12 (6): 578-588. Joshi Asim, Mishra Rohit, Desai Sanket, Chandrani Pratik, Kore Hitesh, Sunder Roma, Hait Supriya, Iyer Prajish, Trivedi Vaishakhi, Choughule Anuradha, Noronha Vanita, Joshi Amit, Patil Vijay, Menon Nandini, Kumar Rajiv, Prabhash Kumar, Dutt Am |
| Digital next-generation sequencing of cell-free DNA for pancreatic cancer. JGH open : an open access journal of gastroenterology and hepatology 2021 4 5 (4): 508-516. Takano Shinichi, Fukasawa Mitsuharu, Shindo Hiroko, Takahashi Ei, Fukasawa Yoshimitsu, Kawakami Satoshi, Hayakawa Hiroshi, Kuratomi Natsuhiko, Kadokura Makoto, Maekawa Shinya, Enomoto Nobuyu |
| Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer. Journal of oncology 2020 2020 8811487. Chen Dongfang, Xu Jianlin, Qiao Rong, Zhao Yizhuo, Chu Tianqing, Han Baohui, Zhong Run |
| TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer. Cancer medicine 2021 Nov . Grote Isabel, Bartels Stephan, Kandt Leonie, Bollmann Laura, Christgen Henriette, Gronewold Malte, Raap Mieke, Lehmann Ulrich, Gluz Oleg, Nitz Ulrike, Kuemmel Sherko, Zu Eulenburg Christine, Braun Michael, Aktas Bahriye, Grischke Eva-Maria, Schumacher Claudia, Luedtke-Heckenkamp Kerstin, Kates Ronald, Wuerstlein Rachel, Graeser Monika, Harbeck Nadia, Christgen Matthias, Kreipe Ha |
| Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Toxicity and Efficacy in Non-Small-Cell Lung Cancer. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): e437. He K, Zhang S, Pang J, Yin J, Zhang J, Mu D, Tang S, Li L, Bao H, Wu X, Wang X, Shao Y, Yu J, Yuan |
| Efficacy and potential resistance mechanisms of afatinib in advanced non-small cell lung cancer patients with EGFR G719X/L861Q/S768I. Cancer 2022 Sep . Pang Lan-Lan, Gan Jia-Di, Tan Jia-Rong, Huang Yi-Hua, Liao Jun, Liang Wei-Ting, Deng Peng-Bo, Fang Wen-Fe |
| Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer. Cancer journal (Sudbury, Mass.) 2022 9 28 (5): 354-362. Wang Zechen, Anderson Karen |
| Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancer. British journal of cancer 2022 Sep . Fernandez-Garcia Daniel, Nteliopoulos Georgios, Hastings Robert K, Rushton Amelia, Page Karen, Allsopp Rebecca C, Ambasager Bana, Gleason Kelly, Guttery David S, Ali Simak, Charles Coombes R, Shaw Jacqueline |
| Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race. The oncologist 2022 Aug . Zimmerman Raquel, Bilen Mehmet A, Heath Elisabeth I, Nandagopal Lakshminarayanan, Swami Umang, Kessel Adam, Jaeger Ellen, Wesolowski Sergiusz, Hernanadez Edgar J, Chipman Jonathan, Mack Alleda, Ravindranathan Deepak, Maughan Benjamin L, Nussenzveig Roberto, Yandell Mark, Kohli Manish, Lilly Michael B, Sartor A Oliver, Agarwal Neeraj, Barata Pedro |
| Comprehensive Analysis of Genomic Alterations in Hepatoid Adenocarcinoma of the Stomach and Identification of Clinically Actionable Alterations. Cancers 2022 08 14 (16): . Zhao Rongjie, Li Hongshen, Ge Weiting, Zhu Xiuming, Zhu Liang, Wan Xiangbo, Wang Guanglan, Pan Hongming, Lu Jie, Han Weido |
| Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 8 41 (3): 485-496. Topham James T, O'Callaghan Chris J, Feilotter Harriet, Kennecke Hagen F, Lee Young S, Li Weimin, Banks Kimberly C, Quinn Katie, Renouf Daniel J, Jonker Derek J, Tu Dongsheng, Chen Eric X, Loree Jonathan |
| Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast Cancer. Cancers 2022 7 14 (13): . Lee Jin Sun, Yost Susan E, Li Sierra Min, Cui Yujie, Frankel Paul H, Yuan Yate-Ching, Schmolze Daniel, Egelston Colt A, Guo Weihua, Murga Mireya, Chang Helen, Bosserman Linda, Yuan Yu |
| Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience. JCO precision oncology 2022 6 6 e2100289. Gerratana Lorenzo, Movarek Michael, Wehbe Firas, Katam Neelima, Mahalingam Devalingam, Donahue Jeannine, Shah Ami, Chae Young K, Mulcahy Mary, Tsarwhas Dean, Villaflor Victoria, Kalyan Aparna, Hussein Maha, Patel Jyoti, Chandra Sunandana, Platanias Leonidas C, Gradishar William, Cristofanilli Massimo, Behdad Am |
| Genetic determinants of lung cancer: Understanding the oncogenic potential of somatic missense mutations. Genomics 2022 6 114 (4): 110401. Dhakar Ramgopal, Dakal Tikam Chand, Sharma Am |
| mTOR pathway gene mutations predict response to immune checkpoint inhibitors in multiple cancers. Journal of translational medicine 2022 6 20 (1): 247. Cheng Lei, Wang Yanan, Qiu Lixin, Chang Yuanyuan, Lu Haijiao, Liu Chenchen, Zhang Bo, Zhou Yan, Bai Hao, Xiong Liwen, Zhong Hua, Nie Wei, Han Baoh |
| Genomic Alteration Spectrum of Non-Small Cell Lung Cancer Patients in East-China Characterized by Tumor Tissue DNA and Cell-Free DNA. OncoTargets and therapy 2022 5 15 571-584. Li Jie, Chen Siwen, Xue Hui, Wang Haoyi, Huang Tianwei, Xie Hongya, He Jiang, Ke Cai, Yu Zhaonan, Ni B |
| Gene Mutations Associated With Clinical Characteristics in the Tumors of Patients With Breast Cancer. Frontiers in oncology 2022 12 778511. Hao Chunfang, Wang Chen, Lu Ning, Zhao Weipeng, Li Shufen, Zhang Li, Meng Wenjing, Wang Shuling, Tong Zhongsheng, Zeng Yanwu, Lu Leil |
| Molecular landscape and therapeutic alterations in Asian soft-tissue sarcoma patients. Cancer medicine 2022 May . Gan Meifu, Zhang Chen, Qiu Liqing, Wang Yue, Bao Hua, Yu Ruoying, Liu Rui, Wu Xue, Shao Yang, Hou Peifeng, Fei Zhengl |
| Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients. Journal of translational medicine 2022 05 20 (1): 211. Liao Hao, Zhang Jiayang, Zheng Tiantian, Liu Xiaoran, Zhong Jianxin, Shao Bin, Dong Xiaoxi, Wang Xiaohong, Du Pan, King Bonnie L, Jia Shidong, Yu Jianjun, Li Huipi |
| Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 3 28 (11): 2270-2277. Lassman Andrew B, Sepúlveda-Sánchez Juan Manuel, Cloughesy Timothy F, Gil-Gil Miguel J, Puduvalli Vinay K, Raizer Jeffrey J, De Vos Filip Y F, Wen Patrick Y, Butowski Nicholas A, Clement Paul M J, Groves Morris D, Belda-Iniesta Cristóbal, Giglio Pierre, Soifer Harris S, Rowsey Steven, Xu Cindy, Avogadri Francesca, Wei Ge, Moran Susan, Roth Patri |
| Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes. Nature cancer 2022 2 1 (4): 452-468. Pleasance Erin, Titmuss Emma, Williamson Laura, Kwan Harwood, Culibrk Luka, Zhao Eric Y, Dixon Katherine, Fan Kevin, Bowlby Reanne, Jones Martin R, Shen Yaoqing, Grewal Jasleen K, Ashkani Jahanshah, Wee Kathleen, Grisdale Cameron J, Thibodeau My Linh, Bozoky Zoltan, Pearson Hillary, Majounie Elisa, Vira Tariq, Shenwai Reva, Mungall Karen L, Chuah Eric, Davies Anna, Warren Mya, Reisle Caralyn, Bonakdar Melika, Taylor Gregory A, Csizmok Veronika, Chan Simon K, Zong Zusheng, Bilobram Steve, Muhammadzadeh Amir, D'Souza Darryl, Corbett Richard D, MacMillan Daniel, Carreira Marcus, Choo Caleb, Bleile Dustin, Sadeghi Sara, Zhang Wei, Wong Tina, Cheng Dean, Brown Scott D, Holt Robert A, Moore Richard A, Mungall Andrew J, Zhao Yongjun, Nelson Jessica, Fok Alexandra, Ma Yussanne, Lee Michael K C, Lavoie Jean-Michel, Mendis Shehara, Karasinska Joanna M, Deol Balvir, Fisic Ana, Schaeffer David F, Yip Stephen, Schrader Kasmintan, Regier Dean A, Weymann Deirdre, Chia Stephen, Gelmon Karen, Tinker Anna, Sun Sophie, Lim Howard, Renouf Daniel J, Laskin Janessa, Jones Steven J M, Marra Marco |
| Combined PIK3CA and FGFR Inhibition With Alpelisib and Infigratinib in Patients With PIK3CA-Mutant Solid Tumors, With or Without FGFR Alterations. JCO precision oncology 2022 2 3 1-13. Hyman David M, Tran Ben, Paz-Ares Luis, Machiels Jean-Pascal, Schellens Jan H, Bedard Philippe L, Campone Mario, Cassier Philippe A, Sarantopoulos John, Vaishampayan Ulka, Chugh Rashmi, Mahipal Amit, Lockhart A Craig, Sessa Cristiana, Zander Thomas, Ng Matthew, Curigliano Giuseppe, Bendiske Jennifer, Chen Xueying, Choudhury Somesh, Graus-Porta Diana, Lewis Nancy, Perez Garcia Jose Manuel, de Miguel-Luken María Jo |
| The role of next-generation sequencing in the examination of signaling genes in Brca1/2-negative breast cancer cases. Annals of human genetics 2022 Dec . Cine Naci, Ugurtas Cansu, Gokbayrak Merve, Aydin Duygu, Demir Gulhan, Kuru Seda, Sunnetci-Akkoyunlu Deniz, Eren-Keskin Seda, Simsek Turgay, Cabuk Devrim, Aksu Maksut Gorkem, Canturk Nuh Zafer, Savli Hak |
| Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations. ESMO open 2022 12 7 (6): 100641. Murugesan K, Necchi A, Burn T C, Gjoerup O, Greenstein R, Krook M, López J A, Montesion M, Nimeiri H, Parikh A R, Roychowdhury S, Schwemmers S, Silverman I M, Vogel |
| Profiling the somatic mutational landscape of breast tumors from Hispanic/Latina women reveals conserved and unique characteristics. Cancer research 2023 5 . Yuan Chun Ding, Hanbing Song, Aaron W Adamson, Daniel Schmolze, Donglei Hu, Scott Huntsman, Linda Steele, Carmina S Patrick, Shu Tao, Natalie Hernandez, Charleen D Adams, Laura Fejerman, Kevin Gardner, Anna María Nápoles, Eliseo J Perez-Stable, Jeffrey N Weitzel, Henrik Bengtsson, Franklin W Huang, Susan L Neuhausen, Elad Z |
| ER+, HER2- advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes. Molecular oncology 2023 3 . Chen Jessica W, Jacot William, Cortés Javier, Krop Ian E, Dent Susan, Harbeck Nadia, De Laurentiis Michelino, Diéras Véronique, Im Young-Hyuck, Stout Thomas J, Schimmoller Frauke, Savage Heidi M, Hutchinson Katherine E, Wilson Timothy |
| The ctDNA-based postoperative molecular residual disease status in different subtypes of early-stage breast cancer. Gland surgery 2023 1 11 (12): 1924-1935. Yang Yang, Zhang Jie, Li Jiao-Yang, Xu Lu, Wang Si-Ning, Zhang Jun-Qi, Xun Zhou, Xia Yu, Cao Jian-Bo, Liu Yang, Shi Li-Yan, Li Wei, Shi Yong-Lei, He Yuan-Ge, Gu De-Jian, Yu Zheng-Yuan, Chen Kai, Lan Ji |
| Lung cancer presenting with central nervous system metastasis: Clinicopathological and molecular analysis of 171 cases. Annals of diagnostic pathology 2023 1 63 152082. Demleitner Madeleine, Erlenbach-Wünsch Katharina, Coras Roland, Erber Ramona, Polifka Iris, Eyüpo?lu Ilker, Fuchs Florian, Hartmann Arndt, Agaimy Abb |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: